Article

Shark conservation risks associated with the use of shark liver oil in SARS-CoV-2 vaccine development

2020-10-15

Abstract excerpt

The COVID-19 pandemic may create new demand for wildlife-generated products for human health, including a shark-derived ingredient used in some vaccines. Adjuvants are a vaccine component that increases efficacy, and some adjuvants contain squalene, a natural compound derived from shark liver oil which is found most abundantly in deep-sea sharks. In recent decades, there has been growing conservation concern assoc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 807144f2-aaa8-54f5-8aeb-e4ea4f3f8797
DOI: 10.1101/2020.10.14.338053

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest

Shark conservation risks associated with the use of shark liver oil in SARS-CoV-2 vaccine developmentDOI 10.1101/2020.10.14.338053Read

How Fish and Shark-Derived Oils Affect Antiviral Immune Response – a Narrative ReviewSemantic proximity Read

Preparation, Supramolecular Aggregation and Immunological Activity of the Bona Fide Vaccine Adjuvant Sulfavant S.Semantic proximity Read

Efficacy of a stable broadly protective subunit vaccine platform against SARS-CoV-2 variants of concernSemantic proximity Read

LiteVax-adjuvanted influenza vaccine induces transient interferon-driven innate activation and accelerates early IgG3 responses in older adultsSemantic proximity Read

Oceanic Breakthroughs: Marine-Derived Innovations in Vaccination, Therapy and Immune HealthSemantic proximity Read

A recombinant SARS-CoV-2 RBD antigen expressed in insect cells elicits immunogenicity and confirms safety in animal modelsSemantic proximity Read

Protective efficacy and immune responses of largemouth bass (Micropterus salmoides) immunized with an inactivated vaccine against the viral hemorrhagic septicemia virus genotype IVa.Semantic proximity Read